Waters Net Long-Term Debt 2010-2025 | WAT
Waters annual/quarterly net long-term debt history and growth rate from 2010 to 2025. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
- Waters net long-term debt for the quarter ending March 31, 2025 was $-0.170B, a 43.33% decline year-over-year.
- Waters net long-term debt for the twelve months ending March 31, 2025 was $-1.260B, a 144.06% decline year-over-year.
- Waters annual net long-term debt for 2024 was $-0.73B, a 193.59% decline from 2023.
- Waters annual net long-term debt for 2023 was $0.78B, a 1200% increase from 2022.
- Waters annual net long-term debt for 2022 was $0.06B, a 62.5% decline from 2021.
| Waters Annual Net Long-Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $-730 |
| 2023 | $780 |
| 2022 | $60 |
| 2021 | $160 |
| 2020 | $-325 |
| 2019 | $535 |
| 2018 | $-850 |
| 2017 | $170 |
| 2016 | $160 |
| 2015 | $205 |
| 2014 | $142 |
| 2013 | $146 |
| 2012 | $186 |
| 2011 | $225 |
| 2010 | $134 |
| 2009 | $92 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $18.028B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $180.563B | 21.85 |
| Intuitive Surgical (ISRG) | United States | $177.754B | 73.68 |
| Edwards Lifesciences (EW) | United States | $46.928B | 31.13 |
| IDEXX Laboratories (IDXX) | United States | $45.454B | 52.24 |
| Alcon (ALC) | Switzerland | $45.309B | 30.62 |
| DexCom (DXCM) | United States | $34.894B | 53.93 |
| IQVIA Holdings (IQV) | United States | $33.859B | 19.13 |
| Mettler-Toledo (MTD) | United States | $26.269B | 31.24 |
| STERIS (STE) | Ireland | $22.671B | 24.97 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.531B | 0.00 |
| Hologic (HOLX) | United States | $14.819B | 16.10 |
| Sysmex ADR (SSMXY) | Japan | $10.682B | 30.30 |
| Penumbra (PEN) | United States | $9.027B | 70.85 |
| Masimo (MASI) | United States | $8.926B | 32.92 |
| Globus Medical (GMED) | United States | $7.375B | 17.57 |
| Glaukos (GKOS) | United States | $5.388B | 0.00 |
| Teleflex (TFX) | United States | $5.179B | 8.55 |
| Integer Holdings (ITGR) | United States | $3.786B | 18.97 |
| TransMedics (TMDX) | United States | $3.657B | 79.50 |
| PROCEPT BioRobotics (PRCT) | United States | $3.083B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.381B | 14.18 |
| Nihon Kohden (NHNKY) | Japan | $2.144B | 24.59 |
| Elekta AB (EKTAY) | Sweden | $1.991B | 17.90 |
| Veracyte (VCYT) | United States | $1.977B | 27.75 |
| Alphatec Holdings (ATEC) | United States | $1.582B | 0.00 |
| Artivion (AORT) | United States | $1.341B | 125.60 |
| OPKO Health (OPK) | United States | $1.086B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.058B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.019B | 5.42 |
| Pulse Biosciences (PLSE) | United States | $1.004B | 0.00 |
| SiBone (SIBN) | United States | $0.735B | 0.00 |
| IRadimed (IRMD) | United States | $0.716B | 36.33 |
| Beta Bionics (BBNX) | United States | $0.643B | 0.00 |
| AxoGen (AXGN) | United States | $0.609B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.555B | 8.64 |
| OrthoPediatrics (KIDS) | United States | $0.553B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.525B | 11.30 |
| Pacific Biosciences Of California (PACB) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.442B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.416B | 9.67 |
| Delcath Systems (DCTH) | United States | $0.397B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.375B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.358B | 0.00 |
| RxSight (RXST) | United States | $0.324B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.314B | 0.00 |
| Neuronetics (STIM) | United States | $0.297B | 0.00 |
| NeuroPace (NPCE) | United States | $0.295B | 0.00 |
| 908 Devices (MASS) | United States | $0.266B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.245B | 14.86 |
| CVRx (CVRX) | United States | $0.217B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.203B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.180B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.131B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.120B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.117B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.108B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.091B | 55.10 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.067B | 0.00 |
| Spectral AI (MDAI) | United States | $0.066B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.053B | 21.44 |
| EDAP TMS S.A (EDAP) | France | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.10 |